Global Cerebral Palsy Treatment Market Size to Reach USD 2.23 billion in 2025 | Emergen Research
The global cerebral palsy treatment market size is expected to reach USD 2.23 billion by 2025, according to laetst study by Emergen Research, expanding at a CAGR of 7.0% during the forecast period. Increasing awareness regarding early diagnosis and treatment of cerebral palsy is anticipated to boost market growth over the forecast period. The demand for cerebral palsy treatment is increasing owing to rising awareness about the condition and its early diagnosis. In addition, technological advancement in the field of neurorehabilitation is expected to propel market growth over the forecast period. However, lack of awareness about CP in low- and middle-income countries is expected to restrain market growth.
Cerebral palsy is a neurological disorder that affects muscle coordination and movement. It is caused by damage to the brain, typically before or during birth. There is no cure for cerebral palsy, but there are treatments that can help improve symptoms and quality of life. The most common treatment for cerebral palsy is physical therapy. This can help to improve muscle strength and coordination, as well as reduce pain. Other treatments include medication, surgery, and assistive devices. With the rising awareness about cerebral palsy and the availability of new treatments, the market for cerebral palsy treatment is expected to grow significantly over the next decade.
Muscle rigidity caused by spastic cerebral palsy causes clumsy movements. Both the arms and legs become rigid. As a result of the tight muscles in the legs, walking becomes challenging. Conversely, patients with dyskinetic cerebral palsy have trouble controlling their hand and arm motions, which makes it challenging for them to walk and perform other tasks. Additionally, ataxic cerebral palsy causes balance problems that cause shaky motions. Stiffness and loopside crawling are two early signs of cerebral palsy.
Diagnostic procedures for cerebral palsy include developmental monitoring, which involves following a patient's progress over time, and developmental screening, which involves administering a brief test to determine whether the patient has any developmental delays, such as movement or motor skill delays. Referrals for additional evaluations are made if the doctor discovers inconsistencies. Intervention services, such as specific government-NGO collaborative plans, are a component of further therapy. Growing knowledge of sophisticated therapeutics for prompt treatment, along with an increase in the incidence of cerebral palsy and related chronic conditions, is expected to fuel market expansion for treatments for the condition in the years to come.
The market for cerebral palsy treatment drugs is anticipated to develop as healthcare spending rises, funded by both public and private expenditures, and as healthcare systems increasingly adopt new, technologically advanced delivery systems. The likelihood of this trend being observed is higher in areas with rising purchasing power parity. It is projected that increasing need for pharmaceutical industry-related research and development investments would further fuel the market's growth for cerebral palsy treatments.
Further key findings from the study suggest:
- Key participants include GlaxoSmithKline, Pfizer, Abbott Laboratories, GW Pharmaceuticals, Merck, Medtronic, Acorda Therapeutics, Cell Cure Neurosciences, Allergen, Meridigen.
- Due to an increase in the prevalence of cerebral palsy worldwide, significant technological advancements, and an increase in the number of product launches, business expansions, and FDA approvals among manufacturing companies and other organisations, the market for cerebral palsy treatments has gained momentum in the research, innovation, and development sectors. Increased knowledge of cerebral palsy therapies and their benefits also supports market expansion.
- Because cerebral palsy is becoming more common and anticonvulsant medications are being approved more frequently by the U.S. Food and Drug Administration, the anticonvulsant segment currently dominates the global market for cerebral palsy treatments. This trend is anticipated to continue during the forecast period (FDA). By illness type, the spastic cerebral palsy sector dominated the global market for cerebral palsy treatments in 2020, accounting for around 80% of all cerebral palsy patients.
- Retail stores and pharmacies accounted for the largest share of the global cerebral palsy treatment market by distribution channel in 2020. This segment is expected to continue to grow as a result of recent advancements in the pharmaceutical industry, rising healthcare and medication costs, increased public access to pharmaceuticals, increased public awareness of cerebral palsy disorders and the need for treatments, and increased health insurance penetration.
- Due to a large increase in investments as well as partnerships and collaborations, North America dominated the cerebral palsy treatment market in 2020. However, due to an increase in efforts and increased funding for the overall R&D of cerebral palsy treatment, Asia-Pacific is predicted to experience significant market growth during the projection period. India and China are additionally anticipated to see rapid CAGR growth in the Asia-Pacific medical device outsourcing market.
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/252
Global Cerebral Palsy Treatment Market: Segmentation
- Surgery Therapy
- Nutrition Therapy
Regional Outlook (Revenue, USD Billion; 2017-2027)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Saudi Arabia
- Rest of MEA
Explore More Reports Emergen Research:
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights